Immunotherapy Drugs Market Research Report
An immune system -stimulating cancer therapy, immunotherapy boosts the immune system's ability to fight cancer cells. As opposed to normal cells, cancerous cells do not usually die. The numbers multiply like an out-of-control copy machine that won't stop creating copies. According to the market database , obtaining immunity against disease and infection is challenging. It is because these abnormal cells frequently mutate, which helps them evade the immune system. Recently, the SWOG Cancer Research reported partial or complete response of immunotherapy in four out of 16 patients with a rare form of cancer known as angiosarcoma. The patients were treated with immunotherapy drugs known as nivolumab and ipilimumab. The response to treatment has been sustained in some cases for more than one year, and at least one patient had their tumors disappear entirely. It was conducted by researchers from National Cancer Institute (NCI) SWOG Cancer Research Network. According to the market